Clinical Trials
5
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
A Study to Investigate the Safety and Efficacy of KQB168 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies
- First Posted Date
- 2025-05-29
- Last Posted Date
- 2025-07-11
- Lead Sponsor
- Kumquat Biosciences Inc.
- Target Recruit Count
- 84
- Registration Number
- NCT06994806
- Locations
- 🇺🇸
NEXT Austin, Austin, Texas, United States
🇺🇸NEXT Huston, Houston, Texas, United States
🇺🇸NEXT Oncology, San Antonio, Texas, United States
A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies
- Conditions
- KRAS G12C MutationKRAS G12S MutationSolid Tumor MalignanciesCRC (Colorectal Cancer)
- Interventions
- First Posted Date
- 2024-12-06
- Last Posted Date
- 2025-07-11
- Lead Sponsor
- Kumquat Biosciences Inc.
- Target Recruit Count
- 128
- Registration Number
- NCT06720987
- Locations
- 🇺🇸
Mayo Clinic, Phoenix, Phoenix, Arizona, United States
🇺🇸Mayo Clinic, Jacksonville, Jacksonville, Florida, United States
🇺🇸Dana Farber Cancer Institute, Boston, Massachusetts, United States
A Study to Investigate the Safety and Efficacy of KQB198 as Monotherapy and in Combination in Participants With Advanced Hematologic Malignancies
- First Posted Date
- 2024-10-17
- Last Posted Date
- 2025-05-07
- Lead Sponsor
- Kumquat Biosciences Inc.
- Target Recruit Count
- 122
- Registration Number
- NCT06645886
- Locations
- 🇩🇪
Universitaetsklinikum Jena, Jena, Thuringia, Germany
🇮🇹IRCCS Azienda Ospedaliero-Universitaria di Bologna - Policlinico di Sant Orsola, Bologna, Italy
🇵🇱Pratia Onkologia Katowice, Katowice, Silesian Voivodeship, Poland
A Study to Investigate the Safety and Efficacy of KQB198 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies
- First Posted Date
- 2024-07-18
- Last Posted Date
- 2025-04-10
- Lead Sponsor
- Kumquat Biosciences Inc.
- Target Recruit Count
- 100
- Registration Number
- NCT06507306
- Locations
- 🇺🇸
Sarah Cannon Research Institute at HealthONE, Denver, Colorado, United States
🇺🇸Sarah Cannon Research Institute at Florida Cancer Specialists - Lake Nona -, Orlando, Florida, United States
🇺🇸Florida Cancer Specialists - Sarasota, Sarasota, Florida, United States